Maviret is used to treat hepatitis C in adults with genotype 1, 2, 3, 4, 5 or 6 (Pan-Genotype).
Marivet is a two-drug combination administered as 3 tablets once a day containing glecaprevir and pibrentasvir. There is no need for ribavirin.
The treatment duration is 8, 12 or 16 weeks depending on past treatment experience.